L. Troin
Université Côte d'Azur(FR)Centre Hospitalier Universitaire de Nice(FR)
Publications by Year
Research Areas
Cutaneous lymphoproliferative disorders research, CAR-T cell therapy research, Cancer Immunotherapy and Biomarkers, Psoriasis: Treatment and Pathogenesis, Cutaneous Melanoma Detection and Management
Most-Cited Works
- → Survival of melanoma patients treated with targeted therapy and immunotherapy after systematic upfront control of brain metastases by radiosurgery(2017)80 cited
- → Diabetes and Blood Glucose Disorders Under Anti-PD1(2018)37 cited
- → Baseline and early functional immune response is associated with subsequent clinical outcomes of PD-1 inhibition therapy in metastatic melanoma patients(2021)23 cited
- → Real-life efficacy of immunotherapy for Sézary syndrome: a multicenter observational cohort study(2024)19 cited
- → Germline variants in exonic regions have limited impact on immune checkpoint blockade clinical outcomes in advanced melanoma(2021)8 cited
- → Evolution of patients with Sézary syndrome after mogamulizumab discontinuation for any cause except progression: a multicentre retrospective study (Moga-stop Study)(2024)5 cited
- → Réactions granulomateuses sur tatouage sous anti-BRAF + anti-MEK révélatrices de fausses progressions(2017)5 cited
- → Real-world outcomes of combined lenvatinib and anti-PD-1 in advanced melanoma: the Lenvamel study, a multicenter retrospective study of the French Group of Skin Cancers (Groupe de Cancérologie Cutanée)(2024)3 cited
- → Dermatomyosite retardée et fatale sous anti-PD1 malgré une réponse complète : une nouvelle complication des anti-PD1(2016)2 cited
- → Safety and results of anti-PD1 combined with radiosurgery for the treatment of melanoma brain metastases.(2017)1 cited